Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

mylan institutional llc - dexmedetomidine hydrochloride (unii: 1018wh7f9i) (dexmedetomidine - unii:67vb76hono) - dexmedetomidine 100 ug in 1 ml

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

ever valinject gmbh - dexmedetomidine hydrochloride - concentrate for solution for infusion - 100 microgram(s)/millilitre - other hypnotics and sedatives; dexmedetomidine

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

accord healthcare inc. - dexmedetomidine hydrochloride (unii: 1018wh7f9i) (dexmedetomidine - unii:67vb76hono) - dexmedetomidine injection is indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting. dexmedetomidine injection should be administered by continuous infusion not to exceed 24 hours. dexmedetomidine injection has been continuously infused in mechanically ventilated patients prior to extubation, during extubation, and post-extubation. it is not necessary to discontinue dexmedetomidine injection prior to extubation. dexmedetomidine injection is indicated for sedation of non-intubated patients prior to and/or during surgical and other procedures. none there are no adequate and well-controlled studies of dexmedetomidine use in pregnant women. in an in vitro human placenta study, placental transfer of dexmedetomidine occurred. in a study in the pregnant rat, placental transfer of dexmedetomidine was observed when radiolabeled dexmedetomidine was administered subcutaneously. thus, fetal exposure sh

Kesatuan Eropah - Inggeris - EMA (European Medicines Agency)

accord healthcare s.l.u. - dexmedetomidine - premedication - psycholeptics - for sedation of adult icu (intensive care unit) patients requiring a sedation level not deeper than arousal in response to verbal stimulation (corresponding to richmond agitation-sedation scale (rass) 0 to -3).for sedation of non-intubated adult patients prior to and/or during diagnostic or surgical procedures requiring sedation, i.e. procedural/awake sedation.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - dexmedetomidine hydrochloride -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - dexmedetomidine hydrochloride -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - dexmedetomidine hydrochloride -

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

viatris limited - dexmedetomidine hydrochloride 0.118 mg/ml equivalent to dexmedetomidine 0.100mg/ml;   - concentrate for infusion - 200 mcg/2ml - active: dexmedetomidine hydrochloride 0.118 mg/ml equivalent to dexmedetomidine 0.100mg/ml   excipient: sodium chloride water for injection - icu sedation: for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine viatris by continuous infusion in these patients should not exceed 24 hours. procedural sedation: for sedation of non-intubated patients prior to and/or during surgical and other procedures.

Kanada - Inggeris - Health Canada

juno pharmaceuticals corp. - dexmedetomidine (dexmedetomidine hydrochloride) - solution - 100mcg - dexmedetomidine (dexmedetomidine hydrochloride) 100mcg - miscellaneous anxiolytics sedatives and hypnotics

Kanada - Inggeris - Health Canada

auro pharma inc - dexmedetomidine (dexmedetomidine hydrochloride) - solution - 100mcg - dexmedetomidine (dexmedetomidine hydrochloride) 100mcg - miscellaneous anxiolytics sedatives and hypnotics